Heparanase helps drive SEVs secretion and alters exosome composition (increase in matrix metalloproteinase-9 (MMP-9), VEGF, hepatic growth factor 2 (HGF2), and receptor activator of nuclear factor κ-B ligand (RANKL)) that impact both tumor and host cell behavior [261]. Here, VEGFA is linked to neoplasm.